Efficacy data and HPV vaccination studies

JAMA

Volumn 302, Issue 24, 2009, Pages 2658-2659

  Baylor, Norman W ^a   Wharton, Melinda ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE; HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18;

ADENOCARCINOMA; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; LETTER; LICENSING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK BENEFIT ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; FEMALE; NOTE; PAPILLOMAVIRUS INFECTION; POSTMARKETING SURVEILLANCE; UTERINE CERVIX TUMOR; VIROLOGY;

FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRODUCT SURVEILLANCE, POSTMARKETING; UTERINE CERVICAL NEOPLASMS;

EID: 73949143712     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1882     Document Type: Letter

References (5)

1. Haug C. The risks and benefits of HPV vaccination. JAMA. 2009;302(7): 795-796.
2. Vaccines and Related Biological Products Advisory Committee: notice of meeting. Federal Register, May 1, 2006 (vol 71, No. 83). US Food and Drug Administration Web site. http://www.fda.gov/ohrms/dockets/98fr/E6-6509.htm. Accessed August 17, 2009.
3. Gardasil package insert. US Food and Drug Administration Web site. http: //www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts /UCM111263.pdf. Accessed August 17, 2009.
4. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24.
5. June 8, 2006 approval letter: human papillomavirus quadrivalent (types 6, 11, 16, 18) vaccine, recombinant. US Food and Drug Administration Web site. http: //www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm111283 .htm. Accessed August 17, 2009.